David M. McIntosh is Director at REXAHN PHARMACEUTICALS, INC. (RNN). They have made 1 open-market trade across 1 company since 2009, most recently 2014-04-14.
CIK 0001317248
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RNN | 125,000 | $655K |
Shares reported on the most recent Form 4, priced at the 2014-04-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RNN | BUY | 2009-07-30 | 2009-08-05 | $0.80 | $2K | -17.0% | -5.4% | -5.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.